[1]白宏晔 甘辉立.呼吸系统疾病在他汀类药物多效性中的获益[J].心血管病学进展,2022,(9):824-827.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.014]
　BAI Hongye,GAN Huili.Benefits of Respiratory Disease in Pleiotropy of Statins[J].Advances in Cardiovascular Diseases,2022,(9):824-827.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.014]
点击复制

呼吸系统疾病在他汀类药物多效性中的获益()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年9期
页码:
824-827
栏目:
综述
出版日期:
2022-09-25

文章信息/Info

Title:
Benefits of Respiratory Disease in Pleiotropy of Statins
作者:
白宏晔1 甘辉立 1; 2
(1.首都医科大学研究生院,北京 100069;2.首都医科大学附属北京安贞医院微创心脏外科中心,北京 100029)
Author(s):
BAI Hongye 1; GAN Huili 1; 2
(1. Capital Medical University Graduate School,Beijing100069,China; 2. Minimal Invasive Cardiac Surgery Centre,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
关键词:
呼吸系统疾病; 他汀类药物; 多效性
Keywords:
Respiratory disease; Statins; Pleiotropy
DOI:
10.16806/j.cnki.issn.1004-3934.2022.09.014
摘要:
随着对他汀类药物研究的不断深入，越来越多的证据表明，他汀类药物还具有抗炎、抗氧化、调节血管内皮功能以及影响细胞代谢等诸多作用，这些独立于降脂作用以外的其他作用即他汀类药物的多效性。现就几种常见呼吸系统疾病在他汀类药物多效性中的获益做一简要介绍。
Abstract:
With the deepening of the research on statins,more and more evidence shows that statins also have many effects,such as anti-inflammatory,antioxidant,regulating vascular endothelial function and affecting cell metabolism,which are independent of other effects other than lipid-lowering,that is,the pleiotropy of statins. This article briefly introduces the benefits of several common respiratory diseases in the pleiotropy of statins

参考文献/References:

[1] 李涛. 他汀类药物临床多效性研究进展[J]. 临床合理用药杂志,2021,14(23):179-181.

[2] Davoudi A,Ahmadi M,Sharifi A,et al. Studying the effect of taking statins before infection in the severity reduction of COVID-19 with machine learning[J]. Biomed Res Int,2021,2021: 9995073.

[3] 张盼,吴婷婷,陈素花,等. 辛伐他汀预处理对人偏肺病毒感染的预防作用及相关机制[J]. 解放军医学杂志,2020,45(2):125-132.

[4] Guerra-De-Blas PDC,Bobadilla-Del-Valle M,Sada-Ovalle I,et al. Simvastatin enhances the immune response against mycobacterium tuberculosis[J]. Front Microbiol,2019,10:2097.

[5] 姚宇,王文军,梁玉灵. 他汀类药物对70例肺栓塞患者预后的影响[J]. 山东大学学报(医学版), 2020,58(11):76-80.

[6] 梁蔚繁,李朝锋. 阿托伐他汀对急性肺栓塞大鼠SIRT2/NF-κB通路及动脉血气指标的影响[J]. 河北医药,2021,43(19):2885-2889.

[7] 刘雪莲,刘艳洁,白洁,等. 阿托伐他汀联合华法林在急性肺栓塞治疗中的应用价值及对患者血清Apelin-13、D-D及BNP水平的影响[J]. 哈尔滨医科大学学报,2020,54(3):314-318.

[8] Li R,Yuan M,Yu S,et al. Effect of statins on the risk of recurrent venous thromboembolism:a systematic review and meta-analysis[J]. Pharmacol Res,2021,165:105413.

[9] Afshar K. Future direction of immunosuppression in lung transplantation[J]. Curr Opin Organ Transplant,2014,19(6):583-590.

[10] 奚吉成,张智彪,王崇军,等. 辛伐他汀联合环孢素A抑制小鼠异位气管移植模型闭塞性细支气管炎发生[J]. 中华器官移植杂志,2019,40(9):5.

[11] Bello I,Sandiumenge A,Coll E,et al. Value of preoperative use of statins as a protective factor for severe graft dysfunction after lung transplantation:a multicenter propensity score analysis[J]. Arch Bronconeumol,2021,57(11):720-722.

[12] 任成山,王关嵩,钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J]. 中华肺部疾病杂志(电子版),2019,12(2):127-141.

[13] Lu Y. Effectiveness of long-term using statins in COPD—A network meta-analysis[J]. Respir Res,2019,20(1):17.

[14] Hopkins RJ,Young RP. Mevalonate signaling,COPD and cancer:the statins and beyond[J]. J Investig Med,2019,67(4):711-714.

[15]Walsh A,Perrem L,Khashan AS,et al. Statins versus placebo for people with chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev,2019,7:CD011959.

[16] Pham DL,Kim SH,Losol P,et al. Association of autophagy related gene polymorphisms with neutrophilic airway inflammation in adult asthma[J]. Korean J Intern Med,2016,31(2):375-385.

[17] 李小丽,夏玉红,陈亚飞,等. 胸腺肽联合辛伐他汀治疗哮喘-慢阻肺重叠综合征老年患者临床观察[J]. 内科,2021,16(6):761-764,839.

[18] 黄兰,将振欢,杜月君. 辛伐他汀对哮喘小鼠细胞自噬和炎症的影响及其机制的实验研究[J]. 临床肺科杂志,2022,27(2):4.

[19] 于霞,武玉栋,梁明珠. 氟伐他汀在中、重度慢性持续期支气管哮喘治疗中的作用观察[J]. 系统医学, 2018,3(21):70-72.

[20] Thomson N. Clinical studies of statins in asthma and COPD[J]. Curr Mol Pharmacol,2017,10(1):60-71.

[21] Zeki AA,Elbadawi-sidhu M. Innovations in asthma therapy:is there a role for inhaled statins?[J]. Expert Rev Respir Med,2018,12(6):461-473.

[22] Thenappan T,Chan SY,Weir EK. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension[J]. Am J Physiol Heart Circ Physiol,2018,315(5):H1322-H1331.

[23] Shimoda LA,Laurie SS. Vascular remodeling in pulmonary hypertension[J]. J Mol Med,2013,91(3):297-309.

[24] Young RP,Hopkins RJ. Possible role of statins in COPD-related pulmonary hypertension[J]. Chest,2010,137(5):1250-1251.

[25] 王康,徐亚伟,彭文辉,等. 心血管疾病在他汀类药物多效性中的获益[J]. 现代生物医学进展,2015,15(16):3149-3153.

[26] Wu K,Tian S,Zhou H,et al. Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation[J]. Biochem Pharmacol,2013,85(12):1753-1760.

[27] 黄邦邦,陈嫒,龚瑾,等. 阿托伐他汀通过调节脂肪酸代谢相关蛋白改善野百合碱诱导的肺高血压大鼠肺动脉平滑肌细胞增殖[J]. 中华高血压杂志,2021,29(9):847-854.

[28] Luzak B,Rywaniak J,Stanczyk L,et al. Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition[J]. Eur J Clin Invest,2012,42(8):864-872.

[29] Luo L,Wu J,Lin T,et al. Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension[J]. Aging,2021,13(8):11954-11968.

[30] Zhang Y,Zeng W,Cheng S,et al. Efficacy and safety of statins for pulmonary hypertension:a meta-analysis of randomised controlled trials[J]. Heart Lung Circ,2017,26(5):425-432.

[31] Calfee CS,Delucchi KL,Sinha P,et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin:secondary analysis of a randomised controlled trial[J]. Lancet Respir Med,2018,6(9):691-698.

[32] 李兰,李寒春,唐凤鸣. 阿托伐他汀钙片用于支气管扩张症疗效观察[J]. 现代临床医学,2017,43(4):263-265.

相似文献/References:

[1]戴秋月 郎吉萍 吕萍 潘杭雨 郭志刚.他汀类药物抗乳腺癌作用的研究进展[J].心血管病学进展,2021,(9):776.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
　DAI Qiuyue,LANG Jiping,LYU Ping,et al.Effect of Statins Against Breast Cancer[J].Advances in Cardiovascular Diseases,2021,(9):776.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[2]杜明亮 王泊然 惠慧 郑晓群.维持血液透析合并冠心病的患者降脂治疗的研究进展[J].心血管病学进展,2023,(12):1084.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.007]
　DU Mingliang,WANG Boran,HUI Hui,et al.Lipid-Lowering Therapy in Maintenance Hemodialysis Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2023,(9):1084.[doi:10.16806/j.cnki.issn.1004-3934.2023.12.007]

备注/Memo

备注/Memo:
收稿日期： 2022-03-26 ???/span> 基金项目： 北京市自然科学基金（ 7172067）
更新日期/Last Update: 2022-10-20